A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial with VEGFR2-EPITOPE Peptide and Gemcitabine for Patients with Locally Advanced, Metastatic, or Unresectable Pancreatic Cancer: Pegasus-PC Study
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Annals of Oncology
Authors: H. Yamaue, M. Miyazawa, N. Mizuno, T. Okusaka, A. Fukutomi, H. Ishii, S. Ohkawa, M. Furukawa, H. Maguchi, M. Ikeda, K. Nishio, Y. Ohashi, T. Tsunoda
Institutions: Wakayama Medical University Hospital, Aichi Cancer Center, National Cancer Center Hospital, National Cancer Center Hospital, Shizuoka Cancer Center, The Cancer Institute Hospital, Kanagawa Prefectural Hospital Organization, Kanagawa Cancer Center, National Hospital Organization Kyushu Cancer Center, Teine Keijinkai Hospital, National Cancer Center Hospital East, Kindai University, The University of Tokyo
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2999339729